London scientists have devised a new approach to drug design that could be the key to destroying superbugs, which pose a major threat to human health across the world.
Researchers at King’s College London (KCL), in collaboration with scientists in the US, have discovered a new method that could prove cheaper and more efficient at dealing with antimicrobial resistance (AMR) by preventing bacteria from becoming resistant to current antibiotics.
